Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengjun Ji

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Biomolecules & Biomedicine|February 3, 2026
HALP score outperforms systemic inflammatory biomarkers for prognosis in locally advanced rectal cancerPeipei Shen, Tiantian Yang, Yawen Cong, et al.
Frontiers in Pharmacology|July 13, 2023
Role of endogenous and exogenous antioxidants in risk of six cancers: evidence from the Mendelian randomization studyJiahao Zhu, Jie Lian, Xin Wang, et al.
Journal of Cancer|February 3, 2021
Integrated IMRT vs segmented 3D-CRT of the chest wall and supraclavicular region for Breast Cancer after modified Radical Mastectomy: An 8-year follow-upYutian Zhao, Jiahao Zhu, Xiaojun Zhang, et al.
Chemico-Biological Interactions|January 24, 2026
Cytochrome P450-Mediated Detoxification and NF-κB/NLRP3 Pathway-Driven Hepatotoxicity of Emodin: Multiomics and laboratory evidenceLili Wu, Siyu Chen, Qiyuan Yang, et al.
Trials|August 5, 2018
Combined pretreatment with <sup>18</sup>F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trialShengjun Ji, Qunchao Hu, Jiahao Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 27, 2025
Reprogramming Tumor-Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer ImmunotherapyJiahao Zhu, Benjie Xu, Rui Hu, et al.
Journal of Cancer|September 14, 2020
Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patientsQingqing Chen, Runjun Shi, Zhengcao Liu, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Biomolecules & Biomedicine|February 3, 2026
HALP score outperforms systemic inflammatory biomarkers for prognosis in locally advanced rectal cancerPeipei Shen, Tiantian Yang, Yawen Cong, et al.
Frontiers in Pharmacology|July 13, 2023
Role of endogenous and exogenous antioxidants in risk of six cancers: evidence from the Mendelian randomization studyJiahao Zhu, Jie Lian, Xin Wang, et al.
Journal of Cancer|February 3, 2021
Integrated IMRT vs segmented 3D-CRT of the chest wall and supraclavicular region for Breast Cancer after modified Radical Mastectomy: An 8-year follow-upYutian Zhao, Jiahao Zhu, Xiaojun Zhang, et al.
Chemico-Biological Interactions|January 24, 2026
Cytochrome P450-Mediated Detoxification and NF-κB/NLRP3 Pathway-Driven Hepatotoxicity of Emodin: Multiomics and laboratory evidenceLili Wu, Siyu Chen, Qiyuan Yang, et al.
Trials|August 5, 2018
Combined pretreatment with <sup>18</sup>F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trialShengjun Ji, Qunchao Hu, Jiahao Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 27, 2025
Reprogramming Tumor-Associated Macrophages via Targeted NAT10 Inhibition to Enhance Colorectal Cancer ImmunotherapyJiahao Zhu, Benjie Xu, Rui Hu, et al.
Journal of Cancer|September 14, 2020
Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patientsQingqing Chen, Runjun Shi, Zhengcao Liu, et al.
Pageof 6